Urmăriți
Luiza Spiru
Luiza Spiru
Profesor de Medicina, Universitatea de Medicina si Farmacie Carol Davila
Adresă de e-mail confirmată pe umfcd.ro - Pagina de pornire
Titlu
Citat de
Citat de
Anul
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
14722015
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA …
PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ...
The Lancet Neurology 8 (7), 619-627, 2009
7142009
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
3062019
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1642018
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
I Ramakers, FRJ Verhey, P Scheltens, H Hampel, H Soininen, P Aalten, ...
Psychological medicine 43 (5), 911-920, 2013
1502013
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
IS van Maurik, SJ Vos, I Bos, FH Bouwman, CE Teunissen, P Scheltens, ...
The Lancet Neurology 18 (11), 1034-1044, 2019
1072019
Do Instrumental Activities of Daily Living Predict Dementia at 1‐and 2‐Year Follow‐Up? Findings from the Development of Screening Guidelines and Diagnostic Criteria for …
SAM Sikkes, PJ Visser, DL Knol, ESM de Lange‐de Klerk, M Tsolaki, ...
Journal of the American Geriatrics Society 59 (12), 2273-2281, 2011
1032011
Development of screening guidelines and clinical criteria for predementia Alzheimer’s disease: the DESCRIPA Study
PJ Visser, FRJ Verhey, M Boada, R Bullock, PP De Deyn, GB Frisoni, ...
Neuroepidemiology 30 (4), 254-265, 2008
992008
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
N Mattsson, C Groot, WJ Jansen, SM Landau, VL Villemagne, ...
Alzheimer's & Dementia 14 (7), 913-924, 2018
792018
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the European prospective DESCRIPA study
M Damian, L Hausner, K Jekel, M Richter, L Froelich, O Almkvist, ...
Dementia and geriatric cognitive disorders 36 (1-2), 1-19, 2013
582013
Progression of Alzheimer disease in Europe: data from the European ICTUS study
B Vellas, L Hausner, L Frolich, C Cantet, V Gardette, E Reynish, S Gillette, ...
Current Alzheimer Research 9 (8), 902-912, 2012
582012
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
P Bosco, A Redolfi, M Bocchetta, C Ferrari, A Mega, S Galluzzi, M Austin, ...
Alzheimer's & Dementia 13 (9), 1013-1023, 2017
372017
Association between later life lifestyle factors and Alzheimer’s disease biomarkers in non-demented individuals: a longitudinal descriptive cohort study
BLR Reijs, SJB Vos, H Soininen, J Lötjonen, J Koikkalainen, ...
Journal of Alzheimer's Disease 60 (4), 1387-1395, 2017
312017
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts
L Chouliaras, G Kenis, PJ Visser, P Scheltens, M Tsolaki, RW Jones, ...
Epigenomics 7 (4), 533-537, 2015
282015
Characteristics of subjective cognitive decline associated with amyloid positivity
O Janssen, WJ Jansen, SJB Vos, M Boada, L Parnetti, T Gabryelewicz, ...
Alzheimer's & Dementia 18 (10), 1832-1845, 2022
262022
Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey
KS Frederiksen, TR Nielsen, I Appollonio, BB Andersen, M Riverol, ...
International Journal of Geriatric Psychiatry 36 (2), 324-333, 2021
242021
Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects
J Norberg, C Graff, O Almkvist, M Ewers, GB Frisoni, L Frölich, H Hampel, ...
Dementia and geriatric cognitive disorders 32 (2), 135-142, 2011
242011
Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
B Dubois, J López-Arrieta, S Lipschitz, T Doskas, L Spiru, S Moroz, ...
Alzheimer's Research & Therapy 15 (1), 39, 2023
182023
Distinctive under-expression profile of inflammatory and redox genes in the blood of elderly patients with cardiovascular disease
E Milanesi, G Manda, M Dobre, E Codrici, IV Neagoe, BO Popescu, ...
Journal of Inflammation Research, 429-442, 2021
162021
A longitudinal study of transitions between informal and formal care in Alzheimer disease using multistate models in the European ICTUS cohort
N Coley, A Gallini, V Gares, V Gardette, S Andrieu, B Vellas, E Reynish, ...
Journal of the American Medical Directors Association 16 (12), 1104. e1-1104. e7, 2015
142015
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20